Assembly Biosciences (ASMB) has provided an announcement.
At Assembly Biosciences, Inc.’s 2024 Annual Meeting, stockholders passed key resolutions, including the approval of the Amended and Restated 2018 Stock Incentive Plan, which now allows for an additional 220,000 shares to be issued, and the Second Amended and Restated 2018 Employee Stock Purchase Plan, which increased the available shares to 164,500 and removed the cap on shares purchasable per period. The company’s Board of Directors was elected, executive officers’ compensation was approved, and Ernst & Young LLP was ratified as the independent auditor for the year. Votes also favored holding annual advisory votes on executive compensation.
For an in-depth examination of ASMB stock, go to TipRanks’ Stock Analysis page.
